MMP Genotype Associations with MS in Humans
A study with 200 participants found a strong association between the MMP2 rs243865 (-1306) TT genotype and multiple sclerosis (MS), with about 10 times higher odds of the disease. The MMP3 rs3025058 5A/6A genotype was also linked to 2.45 times higher odds of MS. Additionally, specific combinations of genotypes indicated even greater risks.
- Tags
- #MSResearch
- Most relevant to
- —
- Human efficacy
- Not yet assessed
- Mechanism
- Not yet assessed
- Evidence strength
- Not yet assessed
- Outcome
- Not yet assessed
Why it matters
These findings highlight the potential genetic factors influencing MS susceptibility, suggesting a need for personalized approaches in MS management.
What this does not prove
The study did not find significant links between the genotypes and clinical factors such as attack frequency or disease duration, indicating that while genetics may influence susceptibility, they do not appear to directly affect disease progression.
Next milestone
No next milestone was established from the available source.
Study facts
- Study design
- Not reported
- Participants / samples
- 200 · basis not reported
- Randomised
- No
- Controlled
- Not reported
- Primary endpoint met
- No
- Relevant MS type
- Not reported
- Publication date
- 2026-10-02
- Evidence reviewed
- Abstract only
- Regulatory approval
- Not reported
- Research areas
- Not classified
Original sources
Supporting passages (6)
sample sizeMethods: The study included 100 MS patients and 100 healthy controls.
randomizedNo
primary endpoint metNo
publication date2026-10-02
findingsThe MMP2 rs243865 (-1306) TT genotype showed a strong positive association with MS, exhibiting approximately 10-fold higher odds of the disease (p < 0.001).
limitationsNo statistically significant association was found between the examined genotypes or haplotypes and clinical parameters, including attack frequency and disease duration (p > 0.05).
AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.